Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
By Stephen J. Nicholls, E. Murat Tuzcu, I. Sipahi, Adam W. Grasso, Paul-Henry Schoenhagen, T. Hu, K. Wolski, T. Crowe, M. Desai, Stanley L. Hazen and 11 more. Journal of the American Medical Association (JAMA), 2007
678 citations recorded by the source corpus.
Subfields: Cancer Research, Endocrinology, Diabetes and Metabolism, Surgery
View Paper: https://www.semanticscholar.org/paper/0ec16bb8c97e5261c281961d0e387926df86c988
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Endocrinology, Diabetes and Metabolism
- I. Graham
- Børge G. Nordestgaard
- Jan Boren
- A. Tybjærg-Hansen
- Marja-Riitta Taskinen
- L. Tokgözoğlu
- C. Lumeng
- S. Nissen
In Surgery
- I. Graham
- Jan Boren
- A. Tybjærg-Hansen
- Børge G. Nordestgaard
- Marja-Riitta Taskinen
- L. Tokgözoğlu
- Peter Libby
Citations in the corpus
- Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial. (2016, background): “52 mmol/L) (15), active liver disease or hepatic dysfunction (11), uncontrolled cardiac arrhythmia (4), creatine kinase level greater than 3 times upper limit of normal (2), history of hereditary muscular disorders (2), known active infection or systemic dysfunctions (2), New York Heart Association ”
- ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). (2011, methodology): “for plaque regression in a meta-analysis of four intervention trials, which involved use of intravascular ultrasound to evaluate changes in coronary atheroma volume.(149) Low plasma concentrations of HDL-C are frequently a characteristic of type 2 diabetes as well as mixed or combined dyslipidaemia,”
- 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. (2016, background): “0 mmol/L (,80 mg/dL), represented the minimum requirement for plaque regression.(290)”
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management (2011, background): “Observational data from four intravascular ultrasound trials (two with statins) showed that lowering plasma apo B lipoprotein concentrations together with simultaneous minor elevation of HDL-C levels achieved plaque regression and stabilization.(79) All of these findings urgently require confirmatio”
- Ambient Air Pollution Exaggerates Adipose Inflammation and Insulin Resistance in a Mouse Model of Diet-Induced Obesity (2009, background): “median number of images in a given population, where n is the number of slices measured in an individual T1-weighted image set.(1)”